RecruitingPhase 3ACTRN12607000225415

Efficacy of intravitreal triamcinolone acetonide before pan retinal photocoagulation for improvement of visual acuity and macular edema in diabetic retinopathy

Sponsor

Eye Research Center, Farabi Eye Hospital

Enrollment

60 participants

Start Date

Nov 1, 2005

Study Type

Interventional

Conditions

Diabetic macular edema in severe non proliferative diabetic retinopathy (NPDR)or proliferative diabetic retinopathy(PDR)

Summary

Purpose was to evaluate efficacy of intravitreal triamcinolone acetonide before pan retinal photocoagulation for improvement of visual acuity and macular edema in diabetic retinopathy. Our hypothesis is that triamcinolone acetonide before PRP helps for decreasing macular edema and improvement of visual acuity

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria1

All diabetic patients with severe NPDR or PDR and same stage macular edema in both eyes (Have or not have CSME in both eyes).

Exclusion Criteria1

Tractional retinal detachment, glaucoma, corticosteroid responders, active ocular surface disease, media opacity precluding visibility of fundus details.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients with Severe NPDR or PDR who need panretinal photocoagulation(PRP) and have macular edema with same stage in both eyes are randomized to two groups. One eye is in the injection group The other eye is active control. in the first group 4 mg triamcinolone acetonide is injected intravitreally 1 week before first session of PRP . PRP is done in 3 sessions 1 week apart.

Locations(1)

Iran, Islamic Republic Of

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000225415